Wöran K; Semmler G; Jachs M; Simbrunner B; Bauer DJM; Binter T; Pomej K; Stättermayer AF; Schwabl P; Bucsics T; Paternostro R; Lampichler K; Pinter M; Trauner M; Mandorfer M; Stift J; Reiberger T; Scheiner B, 2022. Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal Hypertension. Clin Gastroenterol Hepatol 20(2):e251-e266
Paternostro R; Becker J; Hofer BS; Panagl V; Schiffke H; Simbrunner B; Semmler G; Schwabl P; Scheiner B; Bucsics T; Bauer D; Binter T; Trauner M; Mandorfer M; Reiberger T, 2021. The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices. Dig Liver Dis.
Balcar L; Semmler G; Pomej K; Simbrunner B; Bauer D; Hartl L; Jachs M; Paternostro R; Bucsics T; Pinter M; Trauner M; Mandorfer M; Reiberger T; Scheiner B, 2021. Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute-on-chronic liver failure. United European Gastroenterol J 9(4):427-437
Semmler G; Binter T; Kozbial K; Schwabl P; Hametner-Schreil S; Zanetto A; Gavasso S; Chromy D; Bauer DJM; Simbrunner B; Scheiner B; Bucsics T; Stättermayer AF; Pinter M; Steindl-Munda P; Schöfl R; Russo FP; Simioni P; Trauner M; Ferenci P; Reiberger T; Mandorfer M, 2021. Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease. Hepatology 73(4):1275-1289
Jachs M; Hartl L; Schaufler D; Desbalmes C; Simbrunner B; Eigenbauer E; Bauer DJM; Paternostro R; Schwabl P; Scheiner B; Bucsics T; Stättermayer AF; Pinter M; Trauner M; Mandorfer M; Reiberger T, 2021. Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes. Gut 70(9):1758-1767
Simbrunner B; Stadlmann A; Schwabl P; Paternostro R; Bauer DJM; Bucsics T; Scheiner B; Lampichler K; Wöran K; Beer A; Eigenbauer E; Pinter M; Stättermayer AF; Marculescu R; Szekeres T; Trauner M; Mandorfer M; Reiberger T, 2021. Placental growth factor levels neither reflect severity of portal hypertension nor portal-hypertensive gastropathy in patients with advanced chronic liver disease. Dig Liver Dis 53(3):345-352
Pfisterer N; Schmidbauer C; Riedl F; Maieron A; Stadlbauer V; Hennlich B; Schwarzer R; Puespoek A; Bucsics T; Effenberger M; Bota S; Gschwantler M; Peck-Radosavljevic M; Mandorfer M; Madl C; Trauner M; Reiberger T, 2021. Perceptions on the management of varices and on the use of albumin in patients with cirrhosis among GI specialists in Austria. Wien Klin Wochenschr 133(9-10):421-431
Thaler J; Lisman T; Quehenberger P; Hell L; Schwabl P; Scheiner B; Bucsics T; Nieuwland R; Ay C; Trauner M; Pabinger I; Reiberger T; Mandorfer M, 2021. Intraperitoneal Activation of Coagulation and Fibrinolysis in Patients with Cirrhosis and Ascites. Thromb Haemost.
Hartl L; Jachs M; Desbalmes C; Schaufler D; Simbrunner B; Paternostro R; Schwabl P; Bauer DJM; Semmler G; Scheiner B; Bucsics T; Eigenbauer E; Marculescu R; Szekeres T; Peck-Radosavljevic M; Kastl S; Trauner M; Mandorfer M; Reiberger T, 2021. The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes. Hepatol Int 15(5):1160-1173
Simbrunner B; Semmler G; Stadlmann A; Scheiner B; Schwabl P; Paternostro R; Bucsics T; Bauer D; Eigenbauer E; Pinter M; Stättermayer AF; Quehenberger P; Marculescu R; Trauner M; Mandorfer M; Reiberger T, 2020. Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosis. Hepatol Int 14(6):1093-1103
Simbrunner B; Marculescu R; Scheiner B; Schwabl P; Bucsics T; Stadlmann A; Bauer DJM; Paternostro R; Eigenbauer E; Pinter M; Stättermayer AF; Trauner M; Mandorfer M; Reiberger T, 2020. Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease. Liver Int 40(7):1713-1724
Semmler G; Wöran K; Scheiner B; Unger LW; Paternostro R; Stift J; Schwabl P; Bucsics T; Bauer D; Simbrunner B; Stättermayer AF; Pinter M; Trauner M; Reiberger T; Mandorfer M, 2020. Novel reliability criteria for controlled attenuation parameter assessments for non-invasive evaluation of hepatic steatosis. United European Gastroenterol J 8(3):321-331
Scheiner B; Stättermayer AF; Schwabl P; Bucsics T; Paternostro R; Bauer D; Simbrunner B; Schmidt R; Marculescu R; Ferlitsch A; Peck-Radosavljevic M; Pinter M; Trauner M; Reiberger T; Ferenci P; Mandorfer M, 2020. Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension. Liver Int 40(2):393-404
Scheiner B; Semmler G; Maurer F; Schwabl P; Bucsics TA; Paternostro R; Bauer D; Simbrunner B; Trauner M; Mandorfer M; Reiberger T, 2020. Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease. Liver Int 40(1):194-204
Chromy D; Mandorfer M; Bucsics T; Schwabl P; Scheiner B; Schmidbauer C; Aichelburg MC; Ferenci P; Trauner M; Peck-Radosavljevic M; Reiberger T, 2019. High efficacy of interferon-free therapy for acute hepatitis C in HIV-positive patients. United European Gastroenterol J 7(4):507-516
Paternostro R; Reiberger T; Bucsics T, 2019. Elastography-based screening for esophageal varices in patients with advanced chronic liver disease. World J Gastroenterol 25(3):308-329
Semmler G; Simbrunner B; Scheiner B; Schwabl P; Paternostro R; Bucsics T; Stättermayer AF; Bauer D; Pinter M; Ferenci P; Trauner M; Mandorfer M; Reiberger T, 2019. Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertension. J Gastroenterol Hepatol 34(12):2164-2172
Scheiner B; Steininger L; Semmler G; Unger LW; Schwabl P; Bucsics T; Paternostro R; Ferlitsch A; Trauner M; Reiberger T; Mandorfer M, 2019. Controlled attenuation parameter does not predict hepatic decompensation in patients with advanced chronic liver disease. Liver Int 39(1):127-135
Chromy D; Mandorfer M; Bucsics T; Schwabl P; Bauer D; Scheiner B; Schmidbauer C; Lang GF; Szekeres T; Ferenci P; Trauner M; Reiberger T, 2019. Prevalence and Predictors of Hepatic Steatosis in Patients with HIV/HCV Coinfection and the Impact of HCV Eradication. AIDS Patient Care STDS 33(5):197-206
Simbrunner B; Röthenbacher A; Haslacher H; Bauer D; Chromy D; Bucsics T; Schwabl P; Paternostro R; Scheiner B; Trauner M; Mandorfer M; Schwarzinger I; Reiberger T, 2019. Ascitic fluid polymorphic nuclear cell count impacts on outcome of cirrhotic patients with ascites. United European Gastroenterol J 7(5):651-661
Schwabl P; Köppel S; Königshofer P; Bucsics T; Trauner M; Reiberger T; Liebmann B, 2019. Detection of Various Microplastics in Human Stool: A Prospective Case Series. Ann Intern Med 171(7):453-457
Semmler G; Stift J; Scheiner B; Wöran K; Schwabl P; Paternostro R; Bucsics T; Stättermayer AF; Pinter M; Ferlitsch A; Trauner M; Reiberger T; Mandorfer M, 2019. Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension. Dig Dis Sci 64(12):3642-3651
Semmler G; Scheiner B; Schwabl P; Bucsics T; Paternostro R; Chromy D; Stättermayer AF; Trauner M; Mandorfer M; Ferlitsch A; Reiberger T, 2019. The impact of hepatic steatosis on portal hypertension. PLoS One 14(11):e0224506
Pfisterer N; Dexheimer C; Fuchs EM; Bucsics T; Schwabl P; Mandorfer M; Gessl I; Sandrieser L; Baumann L; Riedl F; Scheiner B; Pachofszky T; Dolak W; Schrutka-Kölbl C; Ferlitsch A; Schöniger-Hekele M; Peck-Radosavljevic M; Trauner M; Madl C; Reiberger T, 2018. Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding. Aliment Pharmacol Ther 47(7):966-979
Bucsics T; Hoffman S; Grünberger J; Schoder M; Matzek W; Stadlmann A; Mandorfer M; Schwabl P; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Karner J; Karnel F; Reiberger T, 2018. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis. Liver Int 38(6):1036-1044
Bucsics T; Schoder M; Diermayr M; Feldner-Busztin M; Goeschl N; Bauer D; Schwabl P; Mandorfer M; Angermayr B; Cejna M; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Karner J; Karnel F; Reiberger T, 2018. Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding - A two decades experience. PLoS One 13(1):e0189414
Scheiner B; Stammet PR; Pokorny S; Bucsics T; Schwabl P; Brichta A; Thaler J; Lampichler K; Ba-Ssalamah A; Ay C; Ferlitsch A; Trauner M; Mandorfer M; Reiberger T, 2018. Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function. Wien Klin Wochenschr 130(13-14):446-455
Ferraioli G; De Silvestri A; Reiberger T; Taylor-Robinson SD; de Knegt RJ; Maiocchi L; Mare R; Bucsics T; Atzori S; Tinelli C; Sporea I, 2018. Adherence to quality criteria improves concordance between transient elastography and ElastPQ for liver stiffness assessment-A multicenter retrospective study. Dig Liver Dis 50(10):1056-1061
Chromy D; Schwabl P; Bucsics T; Scheiner B; Strassl R; Mayer F; Aichelburg MC; Grabmeier-Pfistershammer K; Trauner M; Peck-Radosavljevic M; Reiberger T; Mandorfer M, 2018. Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patients. Wien Klin Wochenschr 130(3-4):105-114
Mandorfer M; Bucsics T; Hutya V; Schmid-Scherzer K; Schaefer B; Zoller H; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Ferenci P; Kneussl M; Reiberger T, 2018. Liver disease in adults with α1-antitrypsin deficiency. United European Gastroenterol J 6(5):710-718
Bucsics T; Grasl B; Ferlitsch A; Schwabl P; Mandorfer M; Zinober K; Stern R; Chromy D; Scheiner B; Sieghart W; Peck-Radosavljevic M; Trauner M; Reiberger T, 2018. Point Shear Wave Elastography for Non-invasive Assessment of Liver Fibrosis in Patients with Viral Hepatitis. Ultrasound Med Biol 44(12):2578-2586
Reiberger T; Bucsics T; Paternostro R; Pfisterer N; Riedl F; Mandorfer M, 2018. Small Esophageal Varices in Patients with Cirrhosis-Should We Treat Them? Curr Hepatol Rep 17(4):301-315
Schwabl P; Mandorfer M; Steiner S; Scheiner B; Chromy D; Herac M; Bucsics T; Hayden H; Grabmeier-Pfistershammer K; Ferlitsch A; Oberhuber G; Trauner M; Peck-Radosavljevic M; Reiberger T, 2017. Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease. Aliment Pharmacol Ther 45(1):139-149
Steiner S; Bucsics T; Schwabl P; Mandorfer M; Scheiner B; Aichelburg MC; Grabmeier-Pfistershammer K; Ferenci P; Trauner M; Peck-Radosavljevic M; Reiberger T, 2017. Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna. Wien Klin Wochenschr 129(15-16):517-526
Scheiner B; Parada-Rodriguez D; Bucsics T; Schwabl P; Mandorfer M; Pfisterer N; Riedl F; Sieghart W; Ferlitsch A; Trauner M; Peck-Radosavljevic M; Reiberger T, 2017. Non-selective beta-blocker treatment does not impact on kidney function in cirrhotic patients with varices. Scand J Gastroenterol 52(9):1008-1015
Bucsics T; Schoder M; Goeschl N; Schwabl P; Mandorfer M; Diermayr M; Feldner M; Riedl F; Bauer D; Angermayr B; Cejna M; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Karner J; Karnel F; Reiberger T, 2017. Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practice. Dig Liver Dis 49(12):1360-1367
Bucsics T; Krones E, 2017. Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome. Gastroenterol Rep (Oxf) 5(2):127-137
Pinter M; Haupt L; Hucke F; Bota S; Bucsics T; Trauner M; Peck-Radosavljevic M; Sieghart W, 2017. The impact of thyroid hormones on patients with hepatocellular carcinoma. PLoS One 12(8):e0181878
Reiberger T; Püspök A; Schoder M; Baumann-Durchschein F; Bucsics T; Datz C; Dolak W; Ferlitsch A; Finkenstedt A; Graziadei I; Hametner S; Karnel F; Krones E; Maieron A; Mandorfer M; Peck-Radosavljevic M; Rainer F; Schwabl P; Stadlbauer V; Stauber R; Tilg H; Trauner M; Zoller H; Schöfl R; Fickert P, 2017. Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III). Wien Klin Wochenschr 129(Suppl 3):135-158
Unger LW; Stork T; Bucsics T; Rasoul-Rockenschaub S; Staufer K; Trauner M; Maschke S; Pawloff M; Soliman T; Reiberger T; Berlakovich GA, 2017. The role of TIPS in the management of liver transplant candidates. United European Gastroenterol J 5(8):1100-1107
Scheiner B; Schwabl P; Steiner S; Bucsics T; Chromy D; Aichelburg MC; Grabmeier-Pfistershammer K; Trauner M; Peck-Radosavljevic M; Reiberger T; Mandorfer M, 2016. Interferon-free regimens improve health-related quality of life and fatigue in HIV/HCV-coinfected patients with advanced liver disease: A retrospective study. Medicine (Baltimore) 95(27):e4061
Bucsics T; Schwabl P; Mandorfer M; Bota S; Sieghart W; Ferlitsch A; Trauner M; Reiberger T; Peck-Radosavljevic M, 2016. The trigger matters - outcome of hepatorenal syndrome vs. specifically triggered acute kidney injury in cirrhotic patients with ascites. Liver Int 36(11):1649-1656
Bucsics T; Schwabl P; Mandorfer M; Peck-Radosavljevic M, 2016. Prognosis of cirrhotic patients with fungiascites and spontaneous fungal peritonitis (SFP). J Hepatol 64(6):1452-4
Mandorfer M; Schwabl P; Steiner S; Scheiner B; Chromy D; Bucsics T; Stättermayer AF; Aichelburg MC; Grabmeier-Pfistershammer K; Trauner M; Reiberger T; Peck-Radosavljevic M, 2016. Interferon-free treatment with sofosbuvir/daclatasvir achieves sustained virologic response in 100% of HIV/hepatitis C virus-coinfected patients with advanced liver disease. AIDS 30(7):1039-47
Scheiner B; Mandorfer M; Schwabl P; Payer BA; Bucsics T; Bota S; Aichelburg MC; Grabmeier-Pfistershammer K; Stättermayer A; Ferenci P; Trauner M; Peck-Radosavljevic M; Reiberger T, 2015. The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection. PLoS One 10(11):e0143429
Bucsics T; Mandorfer M; Schwabl P; Bota S; Sieghart W; Ferlitsch A; Trauner M; Peck-Radosavljevic M; Reiberger T, 2015. Impact of acute kidney injury on prognosis of patients with liver cirrhosis and ascites: A retrospective cohort study. J Gastroenterol Hepatol 30(11):1657-65
Schwabl P; Bucsics T; Soucek K; Mandorfer M; Bota S; Blacky A; Hirschl AM; Ferlitsch A; Trauner M; Peck-Radosavljevic M; Reiberger T, 2015. Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites. Liver Int 35(9):2121-8
Mandorfer M; Bota S; Schwabl P; Bucsics T; Pfisterer N; Summereder C; Hagmann M; Blacky A; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Reiberger T, 2014. Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites. PLoS One 9(11):e110503
Mandorfer M; Bota S; Schwabl P; Bucsics T; Pfisterer N; Kruzik M; Hagmann M; Blacky A; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Reiberger T, 2014. Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis. Gastroenterology 146(7):1680-90.e1
Publication list retrieved from NCBI using ImpactPubs
.